Connelly to lead Human Genome Sciences

Connelly to lead Human Genome Sciences

Download Image: Web

WILLIAMSPORT, Pa. - Deirdre Connelly, a 1983 Lycoming graduate, will take the helm as president and CEO of Human Genome Sciences following the company's acquisition by GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies.

HGS, headquartered in Rockville, Md., exists to place new therapies into the hands of those battling serious diseases.

Connelly has served as president, North America Pharmaceuticals, of GSK since February 2009, and previously led Eli Lily and Company as president of U.S. operations.

A native of San Juan, Puerto Rico, Connelly earned a bachelor's degree in economics and marketing from Lycoming. She graduated from Harvard University's Advanced Management Program in 2000. Among her many accolades, she has been named one of "The World's 100 Most Powerful Women" by Forbes and one of Fortune Magazine's "50 Most Powerful Women in Business."

Lycoming College is a four-year, residential liberal arts and sciences school dedicated to the undergraduate education of 1,400 students. Located near the banks of the Susquehanna River in Williamsport, Pa., the College fosters academic vigor, a supportive faculty and successful outcomes. It offers 35 academic majors and is recognized as a Tier 1 educational institution by U.S. News & World Report. Founded in 1812, Lycoming is one of the 50 oldest colleges in the nation.